Masimo Corporation, a leader in noninvasive monitoring technologies, unveiled select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. This release provides a glimpse into the company's performance and strategic positioning.
In the Preliminary Fourth Quarter 2025 Financial Results, Masimo expects revenue to reach approximately $411 million, marking a robust 12% growth on a reported basis compared to the same period last year. This growth signifies Masimo's ability to drive top-line expansion through its innovative product offerings and market penetration strategies.
Looking at the Preliminary Full-Year 2025 Financial Results, Masimo projects revenue of around $1,523 million, reflecting a solid 9% growth rate for the entire year. This sustained growth underscores the company's market strength and customer demand for its cutting-edge solutions.
Revenue Growth
Masimo achieved an impressive 12% growth in revenue for the fourth quarter of 2025 and a solid 9% growth for the full-year, showcasing its ability to consistently drive top-line expansion through market innovation and strategic initiatives.
Earnings Per Share
The non-GAAP earnings per diluted share for Masimo are expected to exceed $1.54 for the fourth quarter and surpass $5.55 for the full-year 2025. These strong earnings projections indicate the company's efficient operational management and profitability.
Shipments
Masimo anticipates delivering approximately 69 thousand noninvasive technology boards and instruments in the fourth quarter of 2025 and around 270 thousand units for the full-year, demonstrating the strong market demand for its advanced healthcare monitoring solutions.
- The robust financial performance in 2025 highlights Masimo's successful execution of its strategic initiatives and value proposition to customers. The company's ability to achieve record levels of incremental contract value with new and existing customers underscores its market leadership and strong customer relationships, setting the stage for continued growth and innovation in the future.
Masimo's outstanding performance in 2025 not only underscores its strong strategic execution and customer-centric approach but also positions the company for sustainable growth and market leadership in the healthcare technology sector. By consistently delivering innovative solutions and expanding its customer base, Masimo remains well-positioned to capitalize on emerging opportunities and drive value creation for its stakeholders.